Keywords: novartis, buys, rights, arrow, rsv, drug, switzerland

Novartis buys rights to Arrow's RSV drug

Article | 11 July 2005

Print This

Switzerland's largest drugmaker, Novartis, says it has entered an exclusive global license deal with the UK's Arrow Therapeutics for A-60444, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in